(Q39601844)

13 September 2017

title

Extent to which low-level use of antiretroviral treatment could curb the AIDS epidemic in sub-Saharan Africa (English)

1 reference

13 September 2017

0 references

anti-retroviral agent

0 references

0 references

1 reference

7

R S Hogg

1 reference

13 September 2017

E Wood

1

1 reference

13 September 2017

P Braitstein

2

1 reference

13 September 2017

J S Montaner

3

1 reference

13 September 2017

M T Schechter

4

1 reference

13 September 2017

M W Tyndall

5

1 reference

13 September 2017

M V O'Shaughnessy

6

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

13 September 2017

1 reference

13 September 2017

volume

355

1 reference

13 September 2017

issue

9221

1 reference

13 September 2017

page(s)

2095-2100

1 reference

Antiviral effect of double and triple drug combinations amongst HIV-infected adults

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

Determinants of the natural history of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

Improved survival among HIV-infected individuals following initiation of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study G

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

One world, one hope: the cost of providing antiretroviral therapy to all nations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

Antiretroviral medication use among injection drug users: two potential futures

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

HIVNET nevirapine trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

Prevention of vertical transmission of HIV: analysis of cost effectiveness of options available in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

Cost-effectiveness of improved treatment services for sexually transmitted diseases in preventing HIV-1 infection in Mwanza Region, Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

A tale of two futures: HIV and antiretroviral therapy in San Francisco.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

Modern antiretroviral therapy improves life expectancy of gay and bisexual males in Vancouver's West End.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

Combination antiretroviral therapy and recent declines in AIDS incidence and mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

Strategies for long-term success in the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2800%2902375-8

7 January 2021

10.1016/S0140-6736(00)02375-8

Identifiers

DOI

1 reference

13 September 2017

1 reference